PharmD Info

A forum for Indian Pharmacy Professionals

Important: Registered today to have the complete access on this forum --- Register Here
Share any Pharmaceutical related news with appropriate reference. Latest Pharmaceutical News, Indian Pharma News,
  • User avatar
#1307
Takeda Pharmaceutical Company Limited, a global, R&D-driven pharmaceutical company, announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a negative opinion, recommending against the authorization of Ninlaro (ixazomib) capsules, an oral proteasome inhibitor for the treatment of patients with relapsed and/or refractory multiple myeloma. Takeda intends to appeal this opinion and request a re-examination by the CHMP.
http://www.pharmabiz.com/NewsDetails.aspx?aid=95466&sid=2
Similar Topics
Topics Statistics Last post
0 Replies 
429 Views
by Admin
01 Aug 2018, 08:09
0 Replies 
700 Views
by Admin
25 Dec 2017, 18:31
List of Drug of Choice
by unbreakable  - 16 Jun 2018, 12:54  - In: Pharm D Topics
0 Replies 
662 Views
by unbreakable
16 Jun 2018, 12:54
What is Drug-eluting stents (DES)?
by Admin  - 08 Feb 2017, 10:45  - In: Pharmacy Education
0 Replies 
1072 Views
by Admin
08 Feb 2017, 10:45
0 Replies 
341 Views
by Admin
27 Jul 2018, 09:57

Tags

Indian Association of Colleges of Pharmacy. A/C N[…]

PharmD Info Online Group Discussion Disc[…]

PCI chalks out plans to allay concerns of educatio[…]

NAAC is in the process of developing a Manual for […]

WELCOME TO OUR E-LEARN COURSE WORK MODULES